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Background: Surgical castration is widely used to sterilize male dogs, but has significant impacts on time to
perform the operation, recovery of the animals as well as cost, which can limit population control programs.
Previous research has shown intratesticular injection of calcium chloride dihydrate (CaCl2) in saline to be a
promising alternative to surgery. However, long-term azoospermia was not maintained at dosages low enough to
avoid side effects. In the search for an optimized formulation, the current investigation is the first study on long-term
sterilization effects of intratesticular injection of CaCl2 in either lidocaine solution or alcohol in dogs. CaCl2 at 20%
concentration in lidocaine solution or alcohol was administered via intratesticular injection to groups of 21
dogs each. The treated animals were examined at 2, 6, and 12 months for sperm production, blood levels of
testosterone, and side effects; at time zero and 12 months for testicular size and semen volume. The experimentally
treated animals were compared to a control group receiving saline injection only.
Results: Testicles of dogs treated with CaCl2 in either diluent significantly decreased in size. After administration of
CaCl2 in lidocaine solution, sterility was achieved for at least 12 months in 75% of treated dogs. However, optimal
long-term contraceptive effectiveness was achieved with CaCl2 in alcohol, which resulted in azoospermia over
the 12-month study period. Testosterone levels significantly decreased following treatment with CaCl2, and
sexual activity disappeared. Although testosterone returned to baseline levels by 12 months for the group
treated with CaCl2 in lidocaine, dogs injected with CaCl2 in alcohol had a 63.6% drop in testosterone level,
which remained at the low end of physiological range throughout the study. No adverse effects were noted.
Conclusions: A single, bilateral intratesticular injection of 20% CaCl2 in 95% ethanol was a reliable method
for induction of sterilization in 18–28 kg male dogs in this study. The approach showed long-term efficacy
and reduced sexual behavior. This chemical method of sterilization might provide an effective, efficient alternative to
surgical castration that can have positive impacts on dog welfare.
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Canine overpopulation remains a problem facing many
countries throughout the world. Alternative methods to
surgical sterilization that are effective, easy to administer,
safe, and affordable would offer immense benefits, allowing
animal welfare organizations, public health programs, and
governments to reach further with limited resources [1].* Correspondence: leocivet@yahoo.it
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unless otherwise stated.An intratesticular injection of calcium chloride dihy-
drate (CaCl2) in solution represents a promising method
for non-surgical sterilization [2-7]. A previous dose-
determination study reported that a 20% solution of CaCl2
in saline demonstrated good long-term efficacy without
the undesirable side effects that occurred with higher dos-
ages [2]. These findings partially confirmed the results of
short-term, histology-based studies on CaCl2 by other in-
vestigators who used a 20% concentration [3,5-7]. How-
ever, when 20% CaCl2 in saline solution, as typically used
for sterilization, was evaluated for efficacy over a longer
period, the effect was not permanent: sperm productiontd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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levels increased to baseline levels by 12 months following
injection [2]. For CaCl2 to be used effectively for canine
sterilization, the formulation must be optimized to ensure
permanent azoospermia.
The effectiveness of CaCl2 as a sterilizing agent may
be augmented by the diluent used in the formulation.
The earliest published abstract on the use of intratesti-
cular injection of CaCl2 for sterilization in a variety of
animals reported that aqueous solutions permitted
higher concentrations, but tinctures in 80%-99% alcohol
had the advantages of less pain, less peripheral inflam-
mation, and more consistent results [8]. Intratesticular
administration of a tincture of CaCl2 in ethanol in dogs
was reported to have anesthetic properties, in compari-
son with saline solutions of CaCl2 [4]. Also, alcohol is
known to have independent utility as a sterilant. In
1998, Yoon and Yoon [9] found that chemical castration
with alcohol alone was as effective as orchiectomy in re-
ducing testosterone levels in blood of rats. Furthermore,
a single injection of 95% ethanol directly into the vas
deferens caused atrophy of the cauda epididymis. Exten-
sive necrosis and exfoliation of the seminiferous elements
were conspicuous [10], with irreversible obstructive necro-
sis [11,12].
In addition, solutions of CaCl2 in other diluents have
been used. Samanta and Jana reported on the effective-
ness of lidocaine derivatives as diluents for CaCl2 che-
mosterilization in dogs and cats [5-7]. For example,
using 1% lignocaine hydrochloride as a base for intrates-
ticular injections of CaCl2 in dogs resulted in complete
degeneration of germ cells in a 45-day trial [6]. The in-
vestigators reported that these changes may have been
due to the necrotizing properties of CaCl2 and/or the
significant reduction in intratesticular and blood levels
of testosterone.
Despite the promising results on the use of CaCl2 as a
nonsurgical sterilization method, little is known about
long-term effectiveness or impact on dog health and be-
havior. This lack of information has hampered the wide-
spread application of CaCl2 to address the problem of
dog overpopulation.
The objective of the current study was to evaluate the
long-term (i.e., 1 year) efficacy of intratesticular injection
of 20% CaCl2 in alcohol versus lidocaine for the relative
ability to halt sperm production and reduce blood levels
of testosterone in dogs. We hypothesized a greater ef-
fectiveness for one or both formulations, as compared to
historical use of 20% CaCl2 in saline alone.
Methods
Animals
For the study, 52 healthy, owned, mixed-breed male dogs
living in a shelter were selected. The dogs were 2 to 6 yearsof age (mean = 3.5 years, SD = 1.1 years) and weighed 18
to 28 kg (mean = 22.9 kg, SD = 2.93 kg). Good health sta-
tus was confirmed by routine blood testing and clinical
examination. To assess the fertility of the dogs, an andro-
logical examination (including physical and ultrasono-
graphic examination and evaluation of semen quality) was
performed before the start of the study. Every dog showed
sexual interest when exposed to a bitch in estrus.
Dogs were routinely de-wormed and vaccinated. The
dogs were housed in private shelters, fed standard com-
mercial dog food twice per day, given water ad libitum,
and not subjected to changes in habits during the study.
Dogs were housed in groups of three in a comfortable
primary enclosure with outdoor runs. Indoor space had
temperature maintained above 15°C and below 26°C and
relative humidity ranging from 30% to 70%.
Investigations were conducted in accordance with
the Principles for the Care and Use of Research Animals,
promulgated by the European Union. The Italian Ministry
of Health (Progetto di Ricerca corrente 2009 IZS SI 11/09:
“Randagismo applicazione e valutazione di metodi in-
novativi per il controllo delle nascite”) approved this
study.
Experimental protocol
At day 0 (T0), the animals were randomly assigned to three
groups using a random number table: two experimental
groups (A and B) of 21 dogs each and a control group (C)
of 10 dogs. The first author was aware of group assign-
ment, but technicians collecting data on the subjects were
blind to condition. Semen evaluation and collection of
blood samples were performed. Subsequently, dogs were
lightly sedated with an intramuscular (IM) injection of 5–
10 mg of acepromazine maleate (Prequillan, Fatro, Italy)
per 10 kg of body weight. The testicular widths were mea-
sured with a caliper. According to the scrotal width, the
correct dosage of solution was injected into each testicle
(see “Preparation and intratesticular injection of CaCl2 so-
lution”). Dogs in group A were injected with CaCl2 in a so-
lution containing 1% lidocaine chlorhydrate. Dogs in group
B were injected with CaCl2 in alcohol. Dogs in group C
were injected with a saline solution.
At 2, 6, and 12 months (T1, T2, T3, respectively), semen
evaluation was performed, and blood samples were taken
for testosterone evaluation. At 12 months (T3), testicular
width was measured. Throughout the trial, the dogs were
under clinical observation.
Preparation and intratesticular injection of CaCl2 solution
To prepare the solution containing 20% CaCl2 and 1%
lidocaine, 20 g of CaCl2 dihydrate powder (Sigma Aldrich
Corporation) was added to a final volume of 100 mL with
a 1% solution of lidocaine chlorhydrate (Salp spa, Italy),
mixed, and sterilized in Falcon tubes.
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pared as follows: 20 g of CaCl2 dihydrate powder (Sigma
Aldrich Corporation) was brought to a final volume of
100 mL of 95% ethanol (Baker Analyzed ACS, JT Baker),
mixed, and sterilized in Falcon tubes.
The dogs received a single, bilateral intratesticular in-
jection of solution (Figure 1) proportional to testicular
width: animals with scrotal diameters of 19–22 millimeters
(mm) wide received 0.8 mL injections, whereas animals
with scrotal diameters of at least 23 mm wide received
1 mL injections [2].Semen volume, total sperm count and motility
Semen was collected by digital manipulation of the penis
using plastic cones (artificial vaginas) (IMV Technologies,
Italia) into sterile graduated tubes at 37°C [2,13,14]. Ejacu-
late volume was measured to include all three semen frac-
tions obtained. Within 30–60 min semen was examined
by computer-assisted sperm analysis (CASA) (IVOS Ver-
sion 12.2; Hamilton Thorne Biosciences Inc., Beverly,
MA, USA), which was validated for a large range of sperm
counts [15,16]. Total sperm count and motility were
obtained. Results were confirmed by optical microscopy
evaluation.Assay for serum testosterone
To determine testosterone levels at time intervals T0 to
T3, dogs received subcutaneous (SC) injections of 1,000
international units (I.U.) of human chorionic gonadotropin
(hCG) (Creative Biomart, CD, Inc.) [2,17]. At 120 minFigure 1 Intratesticular injection. Photograph shows procedure of
single, bilateral intratesticular injection of 1 mL of 20% CaCl2 in
ethanol for sterilization of mature male dogs. Each injection was
performed using a sterile 22-gauge needle that was directed from
the ventral aspect of each testis approximately 0.5 cm from the
epididymal tail towards the cranial aspect of that testis. The solution
was carefully deposited along the entire route by linear infiltration,
while withdrawing needle from proximal to distal end.after the hCG injections, blood was collected as previously
described [2]. Testosterone was measured by a chemilu-
minescence technique (Immulite Immunoassay System,
Siemens).
Routine clinical observations
All the animals were kept under routine clinical obser-
vations from T0 to T3. After the chemical sterilization
procedure, continuous observations were conducted
for the first 72 hours, followed by daily observations
for up to 15 days, followed by observations as indi-
cated by the study protocol. The parameters evaluated
during clinical observation included physiological data
(respiratory rate, salivation, body weight, appetite, rec-
tal temperature, etc.), response to palpation, posture,
vocalization, mental status (submissive, etc.). Behav-
iors indicative of pain or discomfort, sexual behavior
(mounting) and aggressive behavior (growling, snapping)
were carefully evaluated [18].
Measurement of testicular width
Scrotal width was used as an index of testicular size
[19]. At T0 and T3, widths (mm) of the right and left tes-
tes were measured using laboratory calipers. Data were
expressed as a mean between the width of left and right
testicles.
Statistical analyses
All data were summarized for each individual canine sub-
ject by measurement (weight, testosterone level, semen vol-
ume, total sperm count, sperm motility, testicular width),
group (A, B, C), and time point (T0, T1, T2, T3) using the
Microsoft Excel 2011 program (Microsoft Corporation,
Redmond, Washington, USA). The average of the testicular
width measurements were used for analysis. These data
were described in terms of the average and standard devi-
ation (SD) and presented as mean ± SD in the results for
brevity.
Statistical analyses were conducted using Statistica
(StatSoft, Inc. Tulsa, OK, USA). Repeated measures of
analysis of variance (ANOVA), with Time as the within
factor and Group as the between factor, were used to
evaluate the measurements in the three groups (A-C)
across four time points (T0, T1, T2, T3) for testosterone,
total sperm count and motility, or two time points (T0
and T3) for semen volume and testicular width. If the re-
sult of the overall test showed significance, then planned
comparisons were conducted. Dunnett’s test for com-
parison to a control group was used, as well as univari-
ate or multivariate planned comparisons to determine if
the measures changed after treatment and if the treated
groups differed from the control group. A two-tailed sig-
nificance level of P < 0.05 was identified.
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Routine clinical observation
Before the injection of sterilant or control saline, the
mean weight of the dogs was 22.8 ± 2.9 kg. No changes
in body weight during the trial were observed. For all
dogs, values for hematology and clinical chemistry con-
sistently remained within reference ranges.
All animals in the study tolerated the intratesticular in-
jections of CaCl2. Pain parameters did not differ during
the study for most dogs. A few dogs, however, showed
signs of minor pain at needle puncture of the scrotum
during the injection: 2% of dogs injected with either CaCl2
in alcohol, lidocaine solution, or normal saline had ab-
dominal muscle contraction, and 1% vocalized. The minor
transient discomfort probably was caused by needle punc-
ture of the scrotum or fluid pressure over the testicular
capsule. Scrotal ultrasonography (USG) revealed a hypoe-
choic intratesticular area, corresponding to a collection of
the injected fluid (Figure 2).
Even if the injection was performed carefully, seepage
occurred in a few dogs. However, the solution was wiped
away immediately with dry gauze, and no adverse effects
were noticed after the seepage.
During the first two weeks after the CaCl2 injection,
the dogs in groups A and B and the control dogs (group
C) did not experience any agitation, fever, or marked in-
flammatory swelling of the testis or changes in evaluated
parameters. No adverse side effects were noticed at the
2-week period. However, beginning after 24 hours fol-
lowing injection and continuing for the first 3–4 days, a
slight increase in firmness of testes on palpation was no-
ticed in dogs in groups A and B and the control dogs
(group C); the increased firmness was slightly more no-
ticeable in dogs in group A. From 1 week to approxi-
mately 1.5 months in dogs in groups A and B, atrophyFigure 2 Scrotal ultrasonography after intratesticular injection
of CaCl2. A hypoechoic intratesticular area corresponding to a
collection of the injected fluid was observed.of the testes gradually progressed, leaving a small fibrotic
remnant. An interference with sexual behavior (i.e., loss of
libido, mounting and dominance behavior) and aggression
was observed in groups A and B following treatment. In
contrast, no testicular changes or alteration of behavior
were observed in the control group, C.
Total sperm count, sperm motility and semen volume
At T0, the mean total sperm count (x10
6) was 346.2 ±
33.9 in group A, 348.4 ± 32.4 in group B, and 335.9 ±
34.9 in the control group. Analysis of variance proce-
dures indicated a significant interaction of Group and
Time for total sperm count (F = 276; P < 0.001). Further
analyses revealed that this result was due to reduced
total sperm count for experimentally treated dogs, but
not for the control dogs. No significant variation in total
sperm count was noticed at T1, T2, and T3 in the control
group that had received saline injection (F = 1.8; P = 0.18)
(340 ± 23.3; 313.5 ± 40.5; 311.4 ± 21.4, respectively).
Although total sperm count in the experimental groups
A and B did not differ from that of the control group C at
baseline T0 (F = 0.94; P = 0.338), both experimental groups
had significantly lower total sperm count than did the
controls at T1-T3 (F = 11476; P < 0.001).
In groups A and B, all dogs were azoospermic at T1 and
T2. At T3, 17 (81%) dogs in group A were azoospermic,
and 4 dogs (19%) were severely oligospermic (40.5 ± 5.1),
exhibiting only 5% motility (Table 1). The mean total
sperm count in dogs of group A at T3 was 7.7 ± 16.4. At
T3, all dogs of group B were azoospermic. According to
statistical analysis, a significant reduction was observed in
total sperm counts after intratesticular injection of CaCl2
to dogs in group A (F = 2220; p < 0.001) and B (F = 2283;
P < 0.009) (Table 1).
At T0, motility was 90% in group A, 95% in group B, and
80% in the control group (C). Sperm motility in the control
group was 80% at all times tested (T1-T3). Of the 42 treated
dogs, only four that were injected with CaCl2 in lidocaine
had 5% sperm motility (Table 1). Statistical analysis was not
possible due to a lack of variability in the data.
Ejaculate volume was not significantly different across
groups at T0 (Group A: 2.98 ± 0.55; Group B: 3.15 ± 0.68;
Group C: 3.45 ± 0.51). Analysis revealed a significant Time
by Group interaction (F = 46.2, P < 0.001) in which the
groups treated with CaCl2 had lower semen volume at T3
than the control group C (F = 63.5, P < 0.001) (Group A:
2.36 ± 0.53; Group B: 1.64 ± 0.55; Group C: 3.50 ± 0.51).
Semen volumes in both group A (F = 39.5, P < 0.001) and
group B (F = 239.9, P < 0.001) were significantly reduced
from T0 to T3.
Assay of serum testosterone
At T0, the mean values of testosterone levels (ng/dL)
were 456.2 ± 132.4 in group A, 454.6 ± 159.9 in group B,
Table 1 Effects of intratesticular injection of calcium chloride on reproductive parameters at 1 year post-injection
Intratesticular Injection Total sperm count (n. × 106) Sperm motility (%) Serum testosterone
concentration (ng/dL)
Testicular width (mm)
Saline control (group C) 311.4 ± 21.4 (range 279–342) 80% (range 70–85) 735.2 ± 186.4 (range 398–985) 24.8 ± 2.0 (range 22.5-28.5)
CaCl2 in lidocaine (group A) 7.1 ± 16.4 (+) (range 0–47) 5% (range 0–5) 461.1 ± 118.1 (range 225–743) 12.7 ± 1.0 (range 11–15)
CaCl2 in alcohol (group B) 0 – 165.7 ± 37.9 (range 104–246) 12.2 ± 0.9 (range 11–15)
Data for effects of single, bilateral intratesticular injection of CaCl2 at 1 year post-injection (T3) is expressed as the group mean ± standard deviation.
(+) 81% of the dogs remained azoospermic, whereas 19% showed severe oligospermia. (−−) No presence of sperm and, thus, motility, were undetectable.
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tested, testosterone values remained within physiological
range (100–1000 ng/dL) [17] throughout the course of
the study, although a single intratesticular injection of
CaCl2 was sufficient to decrease plasma testosterone
concentrations significantly in the treated dogs. Analyses
revealed an overall effect of Group by Time (F = 10.9; P <
0.001), with treated groups having lower testosterone
after injection than did the control group (F = 165.7;
P < 0.001). In contrast, changes in the serum testoster-
one levels in the control group were not statistically sig-
nificant (P > 0.05).
Figure 3 depicts the levels of serum testosterone
graphically over time. Following the injection of CaCl2
in lidocaine solution (group A), testosterone decreased
significantly for 6 months (F = 0.47; P < 0.003), although
levels at T3 returned to baseline. At 12 months following
injection, testosterone levels for the group treated with
CaCl2 in alcohol (Group B) dropped 63.6%, as compared
to baseline. Testosterone levels in group B decreased sig-
nificantly and remained at the low end of the physio-
logical range throughout the 12-month follow-up period
(F = 65.1; P < 0.001).Figure 3 Effects of intratesticular injection of CaCl2 on serum
testosterone levels over time. Following the injection of CaCl2
in lidocaine solution (group A), testosterone decreased significantly
(F = 0.47; P < 0.003) for up to 6 months, although testosterone levels
at 12 months returned to baseline. After injection of calcium chloride
in alcohol (group B), testosterone levels decreased significantly
(F = 65.1, P < 0.001) throughout the 12-month follow-up period.Measurement of testicular width
Testicular width also varied by Group and Time (F =
412; P < 0.001). Average testicular width at baseline (T0)
was similar across groups. The control group showed
no significant difference in testicular width over time
(P > 0.05).
At T0 versus (vs) T3, the mean values of testicular width
(mm) were 24.7 ± 1.5 vs 12.8 ± 1.0 in group A, 24.8 ± 1.5
vs 12.2 ± 0.9 in group B, and 24.9 ± 2.1 vs 24.9 ± 2.1 in the
control group (C) (Figure 4).
After treatment, the width of scrota had declined
significantly in both of the CaCl2-treated groups (A:
F = 2036; P < 0.001 and B: F = 2235; P < 0.001) and was
narrower than that of the control group (F = 802; P <
0.001). The average reduction in testicular width at T3 was
approximately 50% in both group A and group B.
Discussion
The aim of the current research was to study any poten-
tial improvement in the efficacy of using CaCl2 as a non-
surgical sterilization method due to the chemical nature
of the solvents. In this study, two diluents (lidocaine or
alcohol) were tested for use with CaCl2 as a sterilant for
dogs. Our results indicate that alcohol was a superior so-
lution for CaCl2 administration, resulting in complete
azoospermia over a 12-month period, decreased sexual
behavior, and no side effects.
Alcohol alone is a chemical that causes testicular scler-
osis. A study of intratesticular injection of absolute alcoholFigure 4 Changes in testicular width after intratesticular
injection of CaCl2. At 12 months (T3) after treatment with CaCl2
(group A and group B), significant reductions in testicular width
were observed (*P < 0.001), as compared with no or minimal
changes seen in the control (C) group.
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low as in surgically castrated rats [9]. Studies of ethanol
solutions of CaCl2 have demonstrated the definite advan-
tages of more consistent efficacy, less pain, and less
peripheral inflammation [8].
In our study involving canine male contraception, no
or minimal signs of discomfort were observed following
injection, with variation dependent on the agent injected.
Minor transient pain occurred during the injection, as
any needle inserted through skin will cause somatic pain
for an instant. The explanation for the relative lack of
discomfort following the injection is that afferent nerve
endings associated with pain sensation are located on
the scrotal skin and in the capsule of the testis, rather
than within the testicular and epididymal parenchyma
[20]. Given the anatomy of the testes, severe testicular
pain when experienced is visceral and triggered by rapid
pressure deforming the testicular capsule. During chem-
ical castration, it is important to deliver the injection very
slowly to avoid triggering the testicular pressure receptors.
In our experience, dogs that had been injected with the al-
cohol tincture of CaCl2 exhibited less discomfort on the
day following the injection than those injected with the
lidocaine diluent.
Sperm analysis revealed that the injection of CaCl2 in
alcohol had long-term effectiveness at 1 year post-
treatment, whereas the injection of CaCl2 in lidocaine
solution was effective in all dogs for 6 months. At the 1-
year time point, some of the dogs that had been treated
with CaCl2 in lidocaine solution regained residual pro-
duction of sperm. However, we cannot affirm that these
dogs regained fertility, because the severe oligospermia
and poor motility of sperm were unlikely to result in im-
pregnation. Nevertheless it is not possible to exclude that
these dogs might regain sufficient sperm production in
the future. Regeneration of seminiferous tubules has been
reported eight weeks after treatment with 5% concentra-
tions of CaCl2, but not at higher dosages [5]. However,
our long-term study found that sperm was produced in at
least some dogs injected with CaCl2 in lidocaine. Thus,
our findings differ from reports of short-term studies of
similar concentrations of CaCl2 that concluded that ‘per-
manent’ sterilization had occurred [5,6].
Semen volume decreased significantly in dogs injected
with CaCl2. This was due to a reduction of the second
sperm rich fraction of the ejaculate and indicates poor
semen quality.
For contraception of stray male dogs, desirable methods
require a sufficient reduction in the level of testosterone
and, therefore, suppression of sexual behavior. Although
previous research on CaCl2 in both diluents demonstrated
a statistically significant decrease in serum testosterone
[5-7], it was not stated explicitly whether the testosterone
levels had decreased to below that of physiological range.Prior investigations on the use of CaCl2 in lidocaine solu-
tion reported the necrotizing properties of CaCl2, resulting
in low serum concentrations of testosterone [6,7].
In the current study and our previous work [2], a sig-
nificant decrease in testosterone in all CaCl2-treated
groups was measured, despite the fact that serum testos-
terone remained within normal physiological levels over a
12 month period. In the current study, we also observed
the disappearance of aggressive and sex-related behavior
in the treated dogs throughout the study. To our know-
ledge, the change in level of testosterone needed to result
in a significant decrease in or absence of canine sexual be-
havior has never been quantified. From the current study,
a reduction in testosterone levels to the low end of the
physiological range was sufficient to affect behavior. This
is important because a reduction in aggression and sexual
behavior is usually sought in canine sterilization programs.
The current study is the first to evaluate the long-term
effects of different diluents used in CaCl2 sterilization.
Our findings demonstrate the high potential of 20%
CaCl2 in alcohol as a sterilant for use in stray male dogs.
The sterilant fulfills the principal requirements for appli-
cation to a population of stray canines. A single, bilateral
intratesticular injection for stray dogs is effective in
achieving long-term infertility, inhibits sexual behavior,
does not cause chronic stress to the animal, causes few
inflammatory reactions, lacks other undesirable side ef-
fects, is easily performed, and is economical.
Conclusions
A single, bilateral intratesticular injection of 20% CaCl2
in alcohol produced azoospermia in all dogs at one year,
representing an optimal method for sterilization in male
dogs, whereas the effects of CaCl2 in lidocaine solution
lasted for only six months. The sterilization approach
using CaCl2 in alcohol resulted in a durable reduction of
testosterone, as compared to baseline levels, and reduced
aggressive and sexual behavior. Intratesticular injection
of CaCl2 in alcohol appears to be an effective and reli-
able sterilization method in male dogs, making it a good
potential alternative to surgical castration. Nevertheless
more studies on a larger and more variable population of
dogs in a wider weight range as well as in roaming dogs
are needed to better understand the applicability of this
sterilization method on stray dogs.
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